555 related articles for article (PubMed ID: 29789597)
21. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
Front Immunol; 2021; 12():653989. PubMed ID: 33868295
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic suppression of iNOS expression in human endothelial cells: A potential role of Ezh2-mediated H3K27me3.
Dreger H; Ludwig A; Weller A; Baumann G; Stangl V; Stangl K
Genomics; 2016 Apr; 107(4):145-9. PubMed ID: 26853880
[TBL] [Abstract][Full Text] [Related]
23. Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
Duraisamy AJ; Mishra M; Kowluru RA
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6440-6448. PubMed ID: 29261844
[TBL] [Abstract][Full Text] [Related]
24. LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles.
Li XJ; Zhou F; Li YJ; Xue XY; Qu JR; Fan GF; Liu J; Sun R; Wu JZ; Zheng Q; Liu RP
Acta Pharmacol Sin; 2023 Dec; 44(12):2479-2491. PubMed ID: 37580495
[TBL] [Abstract][Full Text] [Related]
25. Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3.
Zhang X; Wang Y; Yuan J; Li N; Pei S; Xu J; Luo X; Mao C; Liu J; Yu T; Gan S; Zheng Q; Liang Y; Guo W; Qiu J; Constantin G; Jin J; Qin J; Xiao Y
J Exp Med; 2018 May; 215(5):1365-1382. PubMed ID: 29626115
[TBL] [Abstract][Full Text] [Related]
26. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
Au SL; Wong CC; Lee JM; Wong CM; Ng IO
PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
[TBL] [Abstract][Full Text] [Related]
27. EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation.
Zhang T; Yang L; Ke Y; Lei J; Shen S; Shao S; Zhang C; Zhu Z; Dang E; Wang G
Cell Death Dis; 2020 Oct; 11(10):826. PubMed ID: 33011750
[TBL] [Abstract][Full Text] [Related]
28. Role of EZH2-mediated H3K27me3 in placental ADAM12-S expression: implications for fetoplacental growth.
Zhu YN; Gan XW; Pan F; Ni XT; Myatt L; Wang WS; Sun K
BMC Med; 2022 May; 20(1):189. PubMed ID: 35610640
[TBL] [Abstract][Full Text] [Related]
29. Long residence time inhibition of EZH2 in activated polycomb repressive complex 2.
Van Aller GS; Pappalardi MB; Ott HM; Diaz E; Brandt M; Schwartz BJ; Miller WH; Dhanak D; McCabe MT; Verma SK; Creasy CL; Tummino PJ; Kruger RG
ACS Chem Biol; 2014 Mar; 9(3):622-9. PubMed ID: 24304166
[TBL] [Abstract][Full Text] [Related]
30. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.
McCabe MT; Ott HM; Ganji G; Korenchuk S; Thompson C; Van Aller GS; Liu Y; Graves AP; Della Pietra A; Diaz E; LaFrance LV; Mellinger M; Duquenne C; Tian X; Kruger RG; McHugh CF; Brandt M; Miller WH; Dhanak D; Verma SK; Tummino PJ; Creasy CL
Nature; 2012 Dec; 492(7427):108-12. PubMed ID: 23051747
[TBL] [Abstract][Full Text] [Related]
31. GSK126 alleviates the obesity phenotype by promoting the differentiation of thermogenic beige adipocytes in diet-induced obese mice.
Wu X; Wang Y; Wang Y; Wang X; Li J; Chang K; Sun C; Jia Z; Gao S; Wei J; Xu J; Xu Y; Li Q
Biochem Biophys Res Commun; 2018 Jun; 501(1):9-15. PubMed ID: 29654753
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target.
Agarwal P; Alzrigat M; Párraga AA; Enroth S; Singh U; Ungerstedt J; Österborg A; Brown PJ; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
Oncotarget; 2016 Feb; 7(6):6809-23. PubMed ID: 26755663
[TBL] [Abstract][Full Text] [Related]
33. Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells.
Hemming S; Cakouros D; Vandyke K; Davis MJ; Zannettino AC; Gronthos S
Stem Cells Dev; 2016 Jun; 25(12):909-21. PubMed ID: 27168161
[TBL] [Abstract][Full Text] [Related]
34. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.
Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K
Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
[TBL] [Abstract][Full Text] [Related]
36. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency.
Shen X; Liu Y; Hsu YJ; Fujiwara Y; Kim J; Mao X; Yuan GC; Orkin SH
Mol Cell; 2008 Nov; 32(4):491-502. PubMed ID: 19026780
[TBL] [Abstract][Full Text] [Related]
37. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3.
Luo H; Jiang Y; Ma S; Chang H; Yi C; Cao H; Gao Y; Guo H; Hou J; Yan J; Sheng Y; Ren X
Biochem Biophys Res Commun; 2016 Oct; 479(2):253-259. PubMed ID: 27638307
[TBL] [Abstract][Full Text] [Related]
38. Disruption of FOXP3-EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation.
Bamidele AO; Svingen PA; Sagstetter MR; Sarmento OF; Gonzalez M; Braga Neto MB; Kugathasan S; Lomberk G; Urrutia RA; Faubion WA
Cell Mol Gastroenterol Hepatol; 2019; 7(1):55-71. PubMed ID: 30510991
[TBL] [Abstract][Full Text] [Related]
39. Histone methyltransferase enzyme enhancer of zeste homolog 2 counteracts ischemic brain injury via H3K27me3-mediated regulation of PI3K/AKT/mTOR signaling pathway.
Chen M; Fan L; Wu G; Wang H; Gu S
Environ Toxicol; 2023 Sep; 38(9):2240-2255. PubMed ID: 37334851
[TBL] [Abstract][Full Text] [Related]
40. [Distributions of H3K27me3 and its modification enzymes in different tissues of mice].
Wang Y; Wang X; Zhang R; Zhang Z; Wang Y; Yang B; Wang G; Zhang X; Ma F; Xu H; Wu X; Zhang F; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1491-1497. PubMed ID: 29268852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
